See more : Adolfo Domínguez, S.A. (ADZ.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Nextage Therapeutics Ltd (NXTG.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nextage Therapeutics Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Dongguan Chitwing Technology Co., Ltd. (002855.SZ) Income Statement Analysis – Financial Results
- Luxe Holdings Limited (LUX.JO) Income Statement Analysis – Financial Results
- Buakaew Income Fund (BKD.BK) Income Statement Analysis – Financial Results
- KCTech Co., Ltd. (281820.KS) Income Statement Analysis – Financial Results
- Mainstreet Equity Corp. (MEQ.TO) Income Statement Analysis – Financial Results
Nextage Therapeutics Ltd (NXTG.TA)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.nxtg.co.il/
About Nextage Therapeutics Ltd
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 876.00K | 0.00 | 91.00K | 191.00K | 297.00K | 383.00K | 405.00K | 28.00K |
| Cost of Revenue | 651.00K | 0.00 | 75.00K | 154.00K | 90.00K | 87.00K | 134.00K | 12.00K |
| Gross Profit | 225.00K | 0.00 | 16.00K | 37.00K | 207.00K | 296.00K | 271.00K | 16.00K |
| Gross Profit Ratio | 25.68% | 0.00% | 17.58% | 19.37% | 69.70% | 77.28% | 66.91% | 57.14% |
| Research & Development | 976.00K | 1.85M | 2.06M | 808.00K | 1.10M | 6.29M | 2.79M | 3.05M |
| General & Administrative | 1.29M | 1.76M | 1.20M | 800.00K | 1.94M | 2.29M | 2.11M | 1.92M |
| Selling & Marketing | 120.00K | 201.00K | 156.00K | 33.00K | 10.00K | 16.00K | 42.00K | 55.00K |
| SG&A | 1.41M | 1.96M | 1.35M | 833.00K | 1.95M | 2.30M | 2.15M | 1.98M |
| Other Expenses | 1.82M | 19.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.21M | 5.85M | 6.47M | 5.16M | 2.05M | 9.64M | 6.20M | 7.17M |
| Cost & Expenses | 4.86M | 5.85M | 6.54M | 5.31M | 2.14M | 9.72M | 6.33M | 7.18M |
| Interest Income | -159.00K | 19.00K | 176.00K | 0.00 | 0.00 | 589.00K | 5.00K | -1.35M |
| Interest Expense | 50.00K | 25.00K | 159.00K | 106.00K | 241.00K | 0.00 | 27.00K | 263.00K |
| Depreciation & Amortization | 128.00K | 57.00K | 190.00K | 96.00K | 161.00K | 4.44M | 820.00K | 712.00K |
| EBITDA | -4.03M | -5.90M | -7.58M | -15.87M | -4.40M | -4.32M | -5.06M | -7.78M |
| EBITDA Ratio | -459.47% | 0.00% | -6,986.81% | -6,750.79% | -567.34% | -1,127.94% | -1,265.93% | -27,800.00% |
| Operating Income | -3.99M | -5.85M | -7.68M | -15.78M | -4.40M | -10.05M | -6.62M | -7.15M |
| Operating Income Ratio | -455.14% | 0.00% | -8,437.36% | -8,262.30% | -1,482.83% | -2,624.02% | -1,633.58% | -25,539.29% |
| Total Other Income/Expenses | -216.00K | -140.00K | -255.00K | -185.00K | 2.34M | 1.31M | 740.00K | -1.61M |
| Income Before Tax | -4.20M | -5.99M | -7.93M | -15.97M | -2.09M | -8.74M | -5.88M | -8.76M |
| Income Before Tax Ratio | -479.79% | 0.00% | -8,717.58% | -8,359.16% | -702.69% | -2,282.25% | -1,450.86% | -31,282.14% |
| Income Tax Expense | 0.00 | -115.00K | 925.00K | 2.68M | 2.56M | 1.28M | 525.00K | -1.36M |
| Net Income | -3.88M | -5.99M | -7.73M | -15.97M | -2.09M | -8.74M | -5.73M | -8.75M |
| Net Income Ratio | -442.81% | 0.00% | -8,492.31% | -8,359.16% | -703.03% | -2,280.68% | -1,415.31% | -31,235.71% |
| EPS | -0.13 | 0.00 | -0.30 | -1.40 | -1.15 | -6.88 | -6.98 | -18.28 |
| EPS Diluted | -0.13 | 0.00 | -0.30 | -1.40 | -1.15 | -6.88 | -6.98 | -18.28 |
| Weighted Avg Shares Out | 29.18M | 0.00 | 26.03M | 11.43M | 1.82M | 1.27M | 821.00K | 478.48K |
| Weighted Avg Shares Out (Dil) | 29.18M | 0.00 | 26.03M | 11.43M | 1.82M | 1.27M | 821.00K | 478.48K |
No news found for: NXTG.TA
Source: https://incomestatements.info
Category: Stock Reports